UB Paderborn / Katalog / Suche / in CDI

Long‐term effectiveness and acceptability of switching from intravenous to subcutaneous infliximab in patients with inflammatory bowel disease treated with intensified doses: The REMSWITCH‐LT study

Alimentary Pharmacology & Therapeutics (Suppl), 2024-02, Vol.59 (4), p.526-534

2024

Volltextzugriff (PDF)

Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2016-04, Vol.10 (4), p.395-401

2016

Volltextzugriff (PDF)

P733 Long-term effectiveness and acceptability of switching from intravenous to subcutaneous infliximab in patients with inflammatory bowel diseases treated with intensified doses: the REMSWITCH-LT study

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1374-i1374

2024

Volltextzugriff (PDF)

Évaluation de la fréquence d’association des maladies inflammatoires dysimmunitaires (spondyloarthrite, psoriasis ou maladies inflammatoires chroniques de l’intestin) au CHU de Lille

Revue du rhumatisme (Ed. française : 1993), 2023-12, Vol.90, p.A242

2023

Volltextzugriff (PDF)

Infliximab is an effective option in patients with ulcerative colitis previously exposed to full subcutaneous anti-TNF agent: Results from a real-world multicenter study

Digestive and liver disease, 2024-08, Vol.56 (8), p.1312-1318

2024

Volltextzugriff (PDF)

Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator: a Multicentre Cohort Study

Journal of Crohn's and colitis, 2022-11, Vol.16 (10), p.1523-1530

2022

Volltextzugriff (PDF)

Fistula Plug in Fistulising Ano-Perineal Crohn’s Disease: a Randomised Controlled Trial

Journal of Crohn's and colitis, 2016-02, Vol.10 (2), p.141-148

2016

Volltextzugriff (PDF)

Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn's Disease: A Prospective Cohort-Study in High-Risk Patients

Journal of Crohn's and colitis, 2017-01, Vol.11 (1), p.47-52

2017

Volltextzugriff (PDF)

P857 Effectiveness and safety of subcutaneous infliximab in perianal Crohn's disease: a multicentre cohort study

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1587-i1587

2024

Volltextzugriff (PDF)

Ileal or Anastomotic Location of Lesions Does Not Impact Rate of Postoperative Recurrence in Crohn’s Disease Patients Classified i2 on the Rutgeerts Score

Digestive diseases and sciences, 2016-10, Vol.61 (10), p.2986-2992

2016

Volltextzugriff (PDF)

P927 Long-term outcomes of risankizumab in Crohn’s disease: a multicenter GETAID Study

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1686-i1686

2024

Volltextzugriff (PDF)

P766 No difference in progression of disability 2 years after stopping infliximab or immunosuppressant vs. continuing combination therapy in patients with CD in sustained steroid-free remission: a subanalysis of SPARE

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1429-i1431

2024

Volltextzugriff (PDF)

DOP76 Real-world multicenter comparison of effectiveness between tofacitinib and vedolizumab in patients with Ulcerative Colitis after failure to at least one anti-TNF agent

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i120-i120

2022

Volltextzugriff (PDF)

Traitement de la dysplasie colique au cours des MICI

Côlon & rectum, 2010-11, Vol.4 (4), p.218-223

Nachury, M.

2010

Volltextzugriff (PDF)

Cronkhite-Canada syndrome

Annales de dermatologie et de vénéréologie, 2007-08, Vol.134 (8-9), p.709-710

2007

Volltextzugriff (PDF)

Defining and Assessing the Reproducibility of Crohn’s Disease Endoscopic Lesions: A Delphi-like Method from the GETAID

Journal of Crohn's and colitis, 2021-06, Vol.15 (6), p.1000-1008

2021

Volltextzugriff (PDF)

Efficacy, Tolerability, and Safety of Low-Volume Bowel Preparations for Patients with Inflammatory Bowel Diseases: The French Multicentre CLEAN Study

Journal of Crohn's and colitis, 2019-09, Vol.13 (9), p.1121-1130

2019

Volltextzugriff (PDF)

Traitement de la dysplasie colique au cours des MICI : Dysplasie des maladies inflammatoires chroniques de l'intestin

Côlon & rectum, 2010, Vol.4 (4), p.218-223

NACHURY, M

2010

Volltextzugriff (PDF)

Adalimumab for patients with Crohn’s disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S616-S616

2019

Volltextzugriff (PDF)

Importin β Is a Mitotic Target of the Small GTPase Ran in Spindle Assembly

Cell, 2001-01, Vol.104 (1), p.95-106

2001

Volltextzugriff (PDF)

COMBIO : efficacité et tolérance des associations de thérapies ciblées chez les patients atteints de maladies inflammatoires à médiation immunitaire

Revue du rhumatisme (Ed. française : 1993), 2021-12, Vol.88, p.A52-A53

2021

Volltextzugriff (PDF)

Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Diseases: the REMSWITCH Study

Clinical gastroenterology and hepatology, 2023-08, Vol.21 (9), p.2338-2346.e3

2023

Volltextzugriff (PDF)

1001 PRAGMATIC ASSESSMENT OF LIVER FIBROSIS DURING METHOTREXATE THERAPY: COMPARISON OF PATIENTS WITH PSORIASIS, RHEUMATOID ARTHRITIS OR CROHN'S DISEASE

Journal of hepatology, 2010, Vol.52, p.S386-S387

2010

Volltextzugriff (PDF)

The Direction of Transport through the Nuclear Pore Can Be Inverted

Proceedings of the National Academy of Sciences - PNAS, 1999-08, Vol.96 (17), p.9622-9627

1999

Volltextzugriff (PDF)

Efficacy of sacral nerve stimulation for poor functional results of J-pouch ileoanal anastomosis

Techniques in coloproctology, 2014-04, Vol.18 (4), p.355-360

2014

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Long‐term effectiveness and acceptability of switching from intravenous to subcutaneous infliximab in patients with inflammatory bowel disease treated with intensified doses: The REMSWITCH‐LT study

Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease

P733 Long-term effectiveness and acceptability of switching from intravenous to subcutaneous infliximab in patients with inflammatory bowel diseases treated with intensified doses: the REMSWITCH-LT study

Évaluation de la fréquence d’association des maladies inflammatoires dysimmunitaires (spondyloarthrite, psoriasis ou maladies inflammatoires chroniques de l’intestin) au CHU de Lille

Infliximab is an effective option in patients with ulcerative colitis previously exposed to full subcutaneous anti-TNF agent: Results from a real-world multicenter study

Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator: a Multicentre Cohort Study

Fistula Plug in Fistulising Ano-Perineal Crohn’s Disease: a Randomised Controlled Trial

Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn's Disease: A Prospective Cohort-Study in High-Risk Patients

P857 Effectiveness and safety of subcutaneous infliximab in perianal Crohn's disease: a multicentre cohort study

Ileal or Anastomotic Location of Lesions Does Not Impact Rate of Postoperative Recurrence in Crohn’s Disease Patients Classified i2 on the Rutgeerts Score

P927 Long-term outcomes of risankizumab in Crohn’s disease: a multicenter GETAID Study

P766 No difference in progression of disability 2 years after stopping infliximab or immunosuppressant vs. continuing combination therapy in patients with CD in sustained steroid-free remission: a subanalysis of SPARE

DOP76 Real-world multicenter comparison of effectiveness between tofacitinib and vedolizumab in patients with Ulcerative Colitis after failure to at least one anti-TNF agent

Traitement de la dysplasie colique au cours des MICI

Cronkhite-Canada syndrome

Defining and Assessing the Reproducibility of Crohn’s Disease Endoscopic Lesions: A Delphi-like Method from the GETAID

Efficacy, Tolerability, and Safety of Low-Volume Bowel Preparations for Patients with Inflammatory Bowel Diseases: The French Multicentre CLEAN Study

Traitement de la dysplasie colique au cours des MICI : Dysplasie des maladies inflammatoires chroniques de l'intestin

Adalimumab for patients with Crohn’s disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study

Importin β Is a Mitotic Target of the Small GTPase Ran in Spindle Assembly

COMBIO : efficacité et tolérance des associations de thérapies ciblées chez les patients atteints de maladies inflammatoires à médiation immunitaire

Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Diseases: the REMSWITCH Study

1001 PRAGMATIC ASSESSMENT OF LIVER FIBROSIS DURING METHOTREXATE THERAPY: COMPARISON OF PATIENTS WITH PSORIASIS, RHEUMATOID ARTHRITIS OR CROHN'S DISEASE

The Direction of Transport through the Nuclear Pore Can Be Inverted

Efficacy of sacral nerve stimulation for poor functional results of J-pouch ileoanal anastomosis

Suchergebnisse filtern